Analysis of the cost-effectiveness relationship of the empirical antibiotic therapy in patients with community acquired lower respiratory tract infections;Análisis de la relación coste-efectividad del tratamiento antibiótico empírico en pacientes con infecciones del tracto respiratorio inferior adquiridas en la comunidad

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 18, Issue 9, 2000, Pages 445-451

  Bertran M J ^a   Trilla, A ^a   Codina, C ^a   Carne X ^a   Ribas, J ^a   Asenjo, M A ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Community acquired infection; Cost effectiveness; Lower respiratory tract infection; Treatment

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEPHALOSPORIN; MACROLIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

AMBULATORY CARE; ANTIBIOTIC THERAPY; ARTICLE; CHRONIC BRONCHITIS; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DISEASE EXACERBATION; DRUG COST; HOSPITAL ADMISSION; HOSPITAL COST; HUMAN; LOWER RESPIRATORY TRACT INFECTION; SPAIN;

ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; DECISION SUPPORT TECHNIQUES; DIRECT SERVICE COSTS; HUMANS; LUNG DISEASES, OBSTRUCTIVE; MODELS, ECONOMIC; PNEUMONIA;

EID: 0034491223     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Epidemiology of lower respiratory infections
2. Cost-effective treatment of lower respiratory tract infections
3. Prognosis and decisions in pneumonia
4. Community-acquired pneumonia in adults: Guidelines for management
5. Guidelines for the initial management of adults with community-acquired pneumonia
6. Medical outcomes and antimicrobial costs with the use of the American Thoracic Society Guidelines for Outpatients with Community-acquired Pneumonia
7. Modelling the use of three antibiotics in the management of community-acquired pneumonia
8. Antibiotic therapy in exacerbations of COPD
9. Economic evaluation of alternative antibiotic regimens in the management of acute exacerbations of chronic bronchitis
10. A cost-effectiveness study of four different antibiotics in the treatment of acute exacerbations of chronic obstructive pulmonary disease
11. Cost management in community-acquired lower respiratory tract infection
12. Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis
13. A prediction rule to identify low-risk patients with community-acquired pneumonia
14. Recurrent respiratory infections in patients with chronic obstructive bronchitis: Medical treatment and costs
15. Community-acquired pneumonia guidelines - An international comparison: A view from Europe
16. Diagnóstico y tratamiento de la neumonía adquirida en la comunidad
17. Preferences for home vs. hospital care among low risk patients with community-acquired pneumonia
18. A prospective randomized study of inpatient iv. antibiotics for community-acquired pneumonia. The optimal duration of therapy
19. Variations in antimicrobial use and cost in more than 2,000 patients with community-acquired pneumonia
20. Expanding uses of fluoroquinolones: Opportunities and challenges
21. Tratamiento antibiótico empírico inicial de la neumonia adquirada en la comunidad
22. Guidelines for the treatment of acute exacerbations of chronic bronchitis